Published Date: 10/07/2022
This course will review the overall goals and principles of buprenorphine treatment among people with opioid use disorder (OUD). It will review the new buprenorphine practice guidelines and describe how they have created flexibility for the Notification of Intent to prescribe buprenorphine process. Additionally, this course will summarize the pharmacology of buprenorphine compared with other medications for OUD; review best practices for initiation, dose stabilization, maintenance and discontinuation; and discuss clinical cases and recommendations for how to approach patients in various clinical settings.
Katie Fitzgerald Jones, APN, ACHPN is a Palliative and Addiction Nurse Practitioner at VA Boston Healthcare System and PhD candidate at Boston College Connell School of Nursing. Her clinical and research interests include improving pain management, quality of life, and enhancing opioid safety in individuals with cancer and substance use disorder. Her past clinical experience includes developing a sustainable Palliative Care Nurse Practitioner Fellowship at Dana Farber Cancer Institute and Brigham and Women’s Hospital, serving as the Palliative Nurse Director, and creating an innovative Palliative Care Program for older adults. Katie has been an active member of the Harvard Medical School Center for Palliative Care for the past ten years. Her research is funded by the Foundation of Addiction Nursing, Sigma Theta Tau International Honor Society of Nursing, and the National Institute of Nursing Research Predoctoral Fellowship Award (F31). Katie is also a Veterans Health Jonas Mental Health Scholar and American Academy of Nursing Jonas Health Policy Scholar, advocating nationally for equitable policy solutions that meet the needs of people living with chronic pain and addiction. She has authored several manuscripts and book chapters on the intersection between palliative care and substance use disorders and has spoken nationally on various topics.